FDA Clearance Tracker · P020025-S001
EPT-1000 XP CARDIAC ABLATION SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 23, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Feb 23, 2004
Approved
Time to decision
152 days
Received Sep 24, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P020025-S001
- Device name
- EPT-1000 XP CARDIAC ABLATION SYSTEM
- Applicant
- Boston Scientific
- Applicant location
- St Paul, MN
- Received
- Sep 24, 2003
- Decided
- Feb 23, 2004
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P020025
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE BLAZER XP RPM CATHETER WHICH COMBINES THE FEATURES OF THE BLAZER II XP WITH THE REAL TIME POSITION MANAGEMENT (RPM) TRACKING SYSTEM TECHNOLOGY APPROVED FOR THE CHILLI RPM CATHETER.
Source documents
Other decisions for Boston Scientific
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.